Illumina invests $5M into genomics lab in Australia

US-based Illumina, Inc. has announced the opening of a new, fully equipped laboratory, with an investment of $5 million, to help Australian researchers and entrepreneurs make significant scientific breakthroughs in areas such as infectious disease, oncology, genetic disease and agriculture. Known as the Illumina Innovation Collective, the lab will make available the latest in DNA sequencing, array platforms and data analysis tools, all supported by specialist scientific expertise to enable clinicians and researchers to not only understand the genome, but also fully tap into its power. It is the first genomics lab in Australia where Illumina’s training specialists, lab scientists, clinical liaison officers and medical affairs teams are working shoulder to shoulder with genomics leaders, healthcare professionals, and patient communities, to fully realise the potential of genomics.